Veness Adam M
SVP, General Counsel and Sec.
Veness Adam M has filed 3 SEC Form 4 filings (9 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Aug 14, 2026.
On the most recent filing, Veness Adam M is listed as SVP, General Counsel and Sec. at Dianthus Therapeutics, Inc. Inside the rolling window, Veness Adam M reported no open-market purchases and 3 open-market sales totaling $4.6M in DNTH. The largest disclosed transaction in the window is a sale of 30,000 DNTH shares on Jun 17, 2026, worth $2.4M.
Companies traded
Other insiders at DNTH
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$4.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Veness Adam M made?
Veness Adam M has filed 3 SEC Form 4 filings (9 transaction rows) across 1 company since 2026.
Which companies does Veness Adam M trade?
Veness Adam M has filed SEC Form 4 disclosures for 1 company, including DNTH.
When was Veness Adam M's most recent SEC Form 4 filing?
Veness Adam M's most recent SEC Form 4 filing on Tracefour is dated Aug 14, 2026.
What is Veness Adam M's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Veness Adam M is listed as SVP, General Counsel and Sec..
What is Veness Adam M's total buy and sell value in the current window?
Inside the rolling retention window, Veness Adam M bought $0 and sold $4.6M based on SEC Form 4 filings.
What was Veness Adam M's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 30,000 DNTH shares on 2026-06-17, worth $2.4M, per SEC Form 4 filings.